← Human Trials & Peer-Reviewed Studies

Association of vitamin D in individuals with periodontitis: an updated systematic review and meta-analysis.

Plain-language guide to PMID 37312090 (2023): meta-analysis of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
37312090
Journal
BMC oral health
Year
2023
Study type
Meta-Analysis
Authors
Liang F et al. (5 authors)
DOI
10.1186/s12903-023-03120-w

What This Paper Covers, in Plain Language

What It Covers

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a meta-analysis.

The purpose of this Meta-analysis is twofold: (1) compare vitamin D levels in individuals with or without periodontitis; (2) assess the effects of vitamin D supplementation during scaling and root planing (SRP) on periodontal clinical parameters in individuals with periodontitis.

The Cochrane Collaboration Risk of bias (ROB) assessment tool, the risk of bias in non-randomized studies of intervention (ROBINS-I) tool, the Newcastle-Ottawa Quality Assessment Scale (NOS), and Agency for Healthcare Quality and Research (AHRQ) were used to evaluate randomized controlled trial (RCT), non-RCT, case-control study, and cross-sectional study, respectively.

Why It Was Studied

There are differences in vitamin D levels between periodontitis and healthy individuals, but the effect of vitamin D on periodontitis is controversial.

How the Review Was Done

A systematic search was conducted in five databases (PubMed, Web of Science, MEDLINE, EMBASE, and Cochrane library), published from the database inception to 12 September 2022.

What Was Measured

There are differences in vitamin D levels between periodontitis and healthy individuals, but the effect of vitamin D on periodontitis is controversial.

The subject headings attached to it are Dental Scaling, Periodontal Diseases, Periodontitis, Root Planing, Vitamin D and Clinical Trials as Topic.

Author keywords: 25(OH)D, Meta-analysis and Scaling and root planning.

What This Means in Plain Language

This is a meta-analysis of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2023 (BMC oral health), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.